skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 8,983  for All Library Resources

previous page 1 Results 2 3 4 5 next page
Refined by: resource type: Newsletter Articles remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Fit to play: Millonarios confirmed the state of health of Andrés Felipe Román
Material Type:
Newsletter Article
Add to My Research

Fit to play: Millonarios confirmed the state of health of Andrés Felipe Román

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

22
Player ruled out by Boca due to heart abnormality will return to play in Colombia
Material Type:
Newsletter Article
Add to My Research

Player ruled out by Boca due to heart abnormality will return to play in Colombia

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

23
Press Release: Alnylam Announces Date of Planned -2
Material Type:
Newsletter Article
Add to My Research

Press Release: Alnylam Announces Date of Planned -2

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Jun 30, 2023

Digital Resources/Online E-Resources

24
Clinical Trial: Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way

US Fed News Service, Including US State News, 2023

Copyright HT Digital Streams Limited May 10, 2023

Digital Resources/Online E-Resources

25
Tenaya Therapeutics Gets FDA Fast-Track Designation for TN-201 TNYA
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics Gets FDA Fast-Track Designation for TN-201 TNYA

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. May 2, 2023

Digital Resources/Online E-Resources

26
LianBio Shares Rise 11% After Positive Mavacamtem Trial Results
Material Type:
Newsletter Article
Add to My Research

LianBio Shares Rise 11% After Positive Mavacamtem Trial Results

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Apr 26, 2023

Digital Resources/Online E-Resources

27
Millionaires disreced legal action against Boca Juniors for the foiled pass of Andrés Felipe Román
Material Type:
Newsletter Article
Add to My Research

Millionaires disreced legal action against Boca Juniors for the foiled pass of Andrés Felipe Román

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

28
Clinical Trial: The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: The Purpose of This Study is to Compare the Efficacy and Safety of Aficamten (CK-3773274) Compared With Metoprolol Succinate in Adults With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

US Fed News Service, Including US State News, 2023

Copyright HT Digital Streams Limited Mar 15, 2023

Digital Resources/Online E-Resources

29
Clinical Trial: Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2023

Copyright HT Digital Streams Limited Mar 4, 2023

Digital Resources/Online E-Resources

30
Millionaires denies Boca and says that Andrés Felipe Román "cannot be concluded a diagnosis of hypertrophic cardiomyopathy"
Material Type:
Newsletter Article
Add to My Research

Millionaires denies Boca and says that Andrés Felipe Román "cannot be concluded a diagnosis of hypertrophic cardiomyopathy"

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

31
The outrageous cover of half-Argentine after Andrés Román's failed pass to Boca
Material Type:
Newsletter Article
Add to My Research

The outrageous cover of half-Argentine after Andrés Román's failed pass to Boca

CE Noticias Financieras, 2021

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

32
Clinical Trial: Use of Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive Cardiomyopathy: Comparison With the Classical Approach
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Use of Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive Cardiomyopathy: Comparison With the Classical Approach

US Fed News Service, Including US State News, 2023

Copyright HT Digital Streams Limited Feb 15, 2023

Digital Resources/Online E-Resources

33
United States : Data Reinforcing Impact of Bristol Myers Squibb Cardiovascular Portfolio to be Presented at American Heart Association Scientific Sessions 2022
Material Type:
Newsletter Article
Add to My Research

United States : Data Reinforcing Impact of Bristol Myers Squibb Cardiovascular Portfolio to be Presented at American Heart Association Scientific Sessions 2022

MENA Report, 2022

2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info). ;EISSN: 2219-0112

Digital Resources/Online E-Resources

34
Nico Vazquez honored his brother, Santiago, with a moving video: "Remembering is living again"
Material Type:
Newsletter Article
Add to My Research

Nico Vazquez honored his brother, Santiago, with a moving video: "Remembering is living again"

CE Noticias Financieras, 2020

CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLC

Digital Resources/Online E-Resources

35
Alnylam Pharmaceuticals Meets Primary Endpoint in Phase 3 Patisiran Study
Material Type:
Newsletter Article
Add to My Research

Alnylam Pharmaceuticals Meets Primary Endpoint in Phase 3 Patisiran Study

Dow Jones Institutional News, 2022

Copyright Dow Jones & Company Inc. Aug 3, 2022

Digital Resources/Online E-Resources

36
Alnylam Pharma Shares Hit 52-Week High After Positive Patisiran Study
Material Type:
Newsletter Article
Add to My Research

Alnylam Pharma Shares Hit 52-Week High After Positive Patisiran Study

Dow Jones Institutional News, 2022

Copyright Dow Jones & Company Inc. Aug 3, 2022

Digital Resources/Online E-Resources

37
Alnylam Pharmaceuticals Shares Jump 46% Premarket After Patisiran Trial Data
Material Type:
Newsletter Article
Add to My Research

Alnylam Pharmaceuticals Shares Jump 46% Premarket After Patisiran Trial Data

Dow Jones Institutional News, 2022

Copyright Dow Jones & Company Inc. Aug 3, 2022

Digital Resources/Online E-Resources

38
Clinical Trial: The Clinical Research of the Safety and Effectiveness Evaluation for Using Minimally Invasive Transapical Septal Myectomy System to Treat Hypertrophic Obstructive Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: The Clinical Research of the Safety and Effectiveness Evaluation for Using Minimally Invasive Transapical Septal Myectomy System to Treat Hypertrophic Obstructive Cardiomyopathy

US Fed News Service, Including US State News, 2022

Copyright HT Digital Streams Limited Apr 19, 2022

Digital Resources/Online E-Resources

39
Clinical Trial: Cardiac Magnetic Resonance Features and Outcomes of Patients With Non-Compaction Cardiomyopathy - a Retrospective Follow-up From Pakistan
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Cardiac Magnetic Resonance Features and Outcomes of Patients With Non-Compaction Cardiomyopathy - a Retrospective Follow-up From Pakistan

US Fed News Service, Including US State News, 2022

Copyright HT Digital Streams Limited Mar 17, 2022

Digital Resources/Online E-Resources

40
Clinical Trial: SGLT2 Inhibitors in ATTR
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: SGLT2 Inhibitors in ATTR

US Fed News Service, Including US State News, 2022

Copyright HT Digital Streams Limited Feb 11, 2022

Digital Resources/Online E-Resources

Results 21 - 40 of 8,983  for All Library Resources

previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2001  (8)
  2. 2001 To 2005  (22)
  3. 2006 To 2010  (226)
  4. 2011 To 2016  (881)
  5. After 2016  (7,847)
  6. More options open sub menu

Subject 

  1. Cardiomyopathy  (8,977)
  2. Clinical Trials  (2,685)
  3. Heart Failure  (2,506)
  4. Patients  (1,871)
  5. Biotechnology Industry  (1,717)
  6. Disease  (1,351)
  7. Webcasting  (1,347)
  8. R&d  (1,292)
  9. Research & Development  (1,292)
  10. Stockholders  (1,288)
  11. Heart  (1,222)
  12. Drug Dosages  (1,147)
  13. Net Losses  (1,140)
  14. Cardiovascular Disease  (1,133)
  15. Earnings Per Share  (1,122)
  16. Diabetes  (1,062)
  17. Cardiology  (1,052)
  18. Collaboration  (1,023)
  19. Fda Approval  (1,021)
  20. Gene Therapy  (994)
  21. More options open sub menu

Databases 

  1. ProQuest Central  (8,982)
  2. MEDLINE  (1)
  3. More options open sub menu

Language 

  1. English  (8,982)
  2. Urdu  (1)
  3. Arabic  (1)
  4. Spanish  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait